Epinoma
PrivateLast Round
Seed
Oct 21, 2021
Total Funding Raised
$125,000
Company Overview
Epinoma operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Seed round in October 2021.
Epinoma is a biotechnology company that develops epigenetic technology for early disease detection and treatment through its proprietary EpiAmp methyl-preserving amplification platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epinoma Comparables
Compare Epinoma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syndex Bio | 90% | |
| METHYS Dx | 79% | |
| Enrich Bioscience | 78% |
For institutional investors. Book with your work email.
Epinoma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 21, 2021 | ||||
| Accelerator | Sep 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epinoma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SeaX Ventures | Seed |
| Gaingels | Seed |
| SeedtoB Capital | Seed |
| Y Combinator | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2021
SeedtoB Capital led the round, joined by Gaingels and Y Combinator.
- Sep 1, 2021
$125K raised from Y Combinator
For institutional investors. Book with your work email.
Epinoma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epinoma's valuation, stock price, and market status.
Is Epinoma a public or private company?
Epinoma is a private company.
What is the current stock price of Epinoma?
Epinoma is a private company, so its shares have no public market price. Caplight tracks Epinoma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epinoma worth (valuation)?
Valuation information for Epinoma is not publicly available.
Can I buy Epinoma stock?
Epinoma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epinoma's last funding round?
Epinoma's most recent funding round was Seed on October 21, 2021.
Who are the main investors in Epinoma?
Key investors in Epinoma include SeedtoB Capital, Y Combinator.
Will Epinoma IPO soon?
No public IPO plans have been announced for Epinoma.
How can I track Epinoma secondary market activity?
Caplight tracks bids, offers, and trades in Epinoma's shares on secondary markets.